about
Major depressive disorder with psychotic features may lead to misdiagnosis of dementia: a case report and review of the literatureATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia.Late life depression: a global problem with few resourcesA Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE StudyHypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.Cardiac rhythm disturbance in a depressed patient after implantation with a vagus nerve stimulator.Adverse childhood experiences are associated with detrimental hemodynamics and elevated circulating endothelin-1 in adolescents and young adults.Feasibility and Acceptability of Bibliotherapy and Telephone Sessions for the Treatment of Late-life Anxiety Disorders.Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.Subjective total insomnia: an example of sleep state misperception.Searching for the mechanism(s) of ECT's therapeutic effectHealth-related quality of life following ECT in a large community sample.Asenapine-induced restless legs syndrome: differentiation from akathisia.A rest-activity biomarker to predict response to SSRIs in major depressive disorder.Relapse prevention after index electroconvulsive therapy in treatment-resistant depressionA multi-site randomized clinical trial to reduce suicidal ideation in suicidal adult outpatients with Major Depressive Disorder: Development of a methodology to enhance safety.Adverse childhood experiences and blood pressure trajectories from childhood to young adulthood: the Georgia stress and Heart study.Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group.Seizure length and clinical outcome in electroconvulsive therapy using methohexital or thiopental.A randomized controlled trial of telephone-delivered cognitive-behavioral therapy for late-life anxiety disorders.Diagnosis and management of insomnia in older people.Placebo effects in primary insomnia.Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depression in a Patient With an Intracranial Space-Occupying Lesion: A Case Report of Safety.Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity.Health-related quality of life and the practice of electroconvulsive therapy.Setting quantitative thresholds for detecting insomnia in older persons.Nightmares and dysfunctional beliefs about sleep mediate the effect of insomnia symptoms on suicidal ideation.Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT.Age and racial differences in the presentation and treatment of Generalized Anxiety Disorder in primary careNew triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism.A psychometric cut-point to separate emergently suicidal depressed patients from stable depressed outpatients.What the electroconvulsive therapy practitioner needs to know about obstructive sleep apnea.The link between suicide and insomnia: theoretical mechanisms.Insomnia in older adults with generalized anxiety disorder.Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention.The FDA and ECT.Factors affecting sleep quality in patients with psoriasis.Cognitive impairment in rapid-onset dystonia-parkinsonismThe role of ECT in suicide prevention.What characterizes late-life depression?
P50
Q26823012-9BB04677-959C-44AE-A1BE-8128C301C5BFQ26827365-ED2E5606-1C4D-411B-B545-243DFD3781DBQ26995710-AE4E69C9-9045-44B5-B992-ACC86D8DB306Q28315355-0FA17C90-CFFB-45F3-9C6C-4BB6C12BF430Q30245527-A72D2260-623D-493F-B189-528F4B7F5166Q33157326-9553D837-FDA5-4A07-A8D2-7B055E9FDD64Q33754198-7114C795-798E-499E-BECA-C524D6AB371CQ34016370-50983EBB-5430-487B-8991-3B3DCCFDD808Q34024389-EEAE8062-F435-427E-B427-E2E8FD605EDBQ34372909-DA8F5EBE-3803-4B82-A015-D5AC369F5E3BQ34416555-777238E7-D3DC-45A8-A94E-9F249A3B781CQ34484539-63294052-F3FB-410C-8780-F4D7BF1A7CCAQ34542945-8BA68B05-56DF-4EB8-A9AF-9B5D2F12C90EQ35532142-92E54794-8FA7-46AC-85BB-2B9631958B71Q35570903-42A42B67-2EBA-4F65-A30B-4FE01BA6481DQ35582521-B3874EAF-534A-491A-85E0-39C29DF079BBQ35602569-D22F459A-0046-4799-B3F2-046ACB367B87Q36025786-2C2A2FFB-12C2-481D-9592-5BD4AD2C2FF3Q36080430-B70F5A41-C61B-432D-A7A3-8B0D231E1B0CQ36126346-4169BC2E-3D05-4617-953D-5685DAA0D957Q36176461-FCF91EFC-FCA2-49AB-98F5-D42262788B60Q36234439-0A83E47C-6A4B-4876-8669-A5D95691B154Q36253925-00B718A0-141E-4848-8D99-2F89222668BCQ36419739-585C4023-A074-4E14-B447-7168A68A7DAEQ36457662-2DECF195-2B5D-4394-B08F-FA3B2F9E1B0BQ36530431-FA450F6B-8957-48A4-A909-709811EB98BCQ36530436-5202083A-9F54-43AB-8D32-2C15F69A3302Q36711426-30A739F7-8421-40BF-93D4-A0D666946DB9Q36938573-6DE286A2-E4DF-4143-8D72-DF9EAD720A02Q37121324-43EDB3BC-9E1F-40AC-BD3E-C09220185CBEQ37183291-EEAF6F2C-569D-4A81-9D69-E1B1332C06CEQ37200533-5B871F82-D1B6-4E06-9A77-BAEA6D667FADQ37217247-720B2D38-4EA9-422C-ABFC-DA13ADE3BC61Q37234251-B402EEEC-A04E-4363-8188-7281D21365E5Q37345033-4F3DFD72-9AA1-4033-9714-21A0E61C3A99Q37473365-6B858C3E-91A9-4239-9D1D-49EE7886204CQ37640431-1AB87B20-934B-4E0F-9D5F-68EA7A47CE7EQ37649763-4787D2A7-A199-40E5-850C-759CA4C97C80Q38148994-CFE5B5E3-C367-45C7-B9CB-EBDDBC166DBBQ38162512-71A243AF-98C9-460B-8A2D-D8A401ED7389
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
W Vaughn McCall
@ast
W Vaughn McCall
@en
W Vaughn McCall
@es
W Vaughn McCall
@nl
W Vaughn McCall
@sl
type
label
W Vaughn McCall
@ast
W Vaughn McCall
@en
W Vaughn McCall
@es
W Vaughn McCall
@nl
W Vaughn McCall
@sl
altLabel
Vaughn McCall
@en
prefLabel
W Vaughn McCall
@ast
W Vaughn McCall
@en
W Vaughn McCall
@es
W Vaughn McCall
@nl
W Vaughn McCall
@sl
P106
P31
P496
0000-0001-5035-7858